BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22879438)

  • 1. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
    Rosner MH; Dalkin AC
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia and bone resorption in malignancy.
    Walls J; Bundred N; Howell A
    Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Refractory hypercalcemia in patient with lung cancer].
    Grzywacz A; Dziuk M; Niemczyk S
    Pol Merkur Lekarski; 2014 Apr; 36(214):261-4. PubMed ID: 24868900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
    Reagan P; Pani A; Rosner MH
    Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS; MacDonald SM; Chik CL; Bruera E
    J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Management of Malignancy-Associated Hypercalcemia.
    Dellay B; Groth M
    Adv Emerg Nurs J; 2016; 38(1):15-25; quiz E1. PubMed ID: 26817427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
    Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onco-nephrology: glomerular diseases with cancer.
    Cambier JF; Ronco P
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1701-12. PubMed ID: 22904123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
    Miyauchi A
    Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
    Tai N; Inoue D
    Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR
    Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-induced hypercalcemia.
    Lumachi F; Brunello A; Roma A; Basso U
    Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy.
    Maier JD; Levine SN
    J Intensive Care Med; 2015 Jul; 30(5):235-52. PubMed ID: 24130250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab in hypercalcemia of malignancy: a case series.
    Dietzek A; Connelly K; Cotugno M; Bartel S; McDonnell AM
    J Oncol Pharm Pract; 2015 Apr; 21(2):143-7. PubMed ID: 24415364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy].
    Tfelt-Hansen J; Brixen KT; Mosekilde L; Schwarz P
    Ugeskr Laeger; 2005 Feb; 167(8):924-6. PubMed ID: 15789851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.